News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UCB Group (UCBJF.PK), Altea Therapeutics Leaders Elected Georgia Bio Co-Chairs for 2008


12/17/2007 10:32:50 AM

ATLANTA--(BUSINESS WIRE)--UCB’s U.S. President Fabrice Egros, Ph.D., and Altea Therapeutics President and CEO Eric Tomlinson, DSc, Ph.D., were elected co-chairs of Georgia Bio’s Board of Directors for 2008. Drs. Egros and Tomlinson succeed AtheroGenics President and CEO Russell Medford, M.D., Ph.D. Dr. Medford will remain on the Georgia Bio Board and Executive Committee as Immediate past Chair.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES